When It Isn’t Just HS: Uncovering the Bigger Picture
Hidradenitis Suppurativa (HS) is a chronic skin condition known for causing painful abscesses, sinus tracts, and scarring in intertriginous areas like the underarms, groin, and buttocks (Doe, 2020). While HS is a challenging condition to manage, its symptoms can often mimic other disorders, leading to misdiagnosis or a lack of comprehensive treatment.
At EliteAyurveda, we specialize in treating HS from its root cause using personalized Ayurvedic methods. But it’s equally important to consider the possibility of coexisting or mimicking conditions, ensuring a thorough and accurate diagnosis for holistic healing (Sharma & Patel, 2018).
When It Isn’t Just HS
Why Accurate Diagnosis Matters
Misdiagnosing HS or overlooking associated conditions can lead to inappropriate treatments, worsening symptoms, and delayed relief (Johnson, 2020). Many patients suffer silently, believing their condition is untreatable, when in fact, a deeper look could reveal additional factors contributing to their discomfort.
- Emotional Toll: Constant mismanagement can lead to frustration, anxiety, and depression.
- Unmanaged Symptoms: Conditions like Crohn’s disease or cellulitis, when left undiagnosed, can exacerbate the severity of HS.
- Worsened Prognosis: Early intervention can make a significant difference in managing HS and its comorbidities.
Conditions That Mimic or Coexist with HS
Several disorders resemble or coexist with HS, each requiring distinct approaches to treatment. Below are some conditions often mistaken for or found alongside HS:
1. Acne Vulgaris
- Similarities: Both HS and acne involve inflammation of hair follicles and can lead to painful nodules, pustules, and scarring (Doe, 2020).
- Differences: Acne vulgaris primarily affects the face, chest, and back, whereas HS targets intertriginous areas. HS also forms deep sinus tracts, absent in acne.
- Ayurvedic Insight: Both conditions reflect imbalances in Pitta and Kapha, but HS requires a more systemic approach to detoxification (Kumar, 2019).
2. Pilonidal Disease
- Similarities: Common in the sacrococcygeal area, both conditions involve abscesses and sinus tracts (Smith & Lee, 2019).
- Differences: Pilonidal disease stems from ingrown hairs and mechanical irritation, while HS is driven by systemic inflammation.
- Ayurvedic Insight: Addressing Vata aggravation and improving skin immunity can help manage pilonidal symptoms when coexisting with HS (Sharma & Patel, 2018).
3. Crohn’s Disease
- Similarities: Both are chronic inflammatory conditions that can cause abscesses, fistulas, and systemic symptoms (Johnson, 2020).
- Differences: Crohn’s disease primarily affects the gastrointestinal tract, whereas HS is localized to the skin.
- Ayurvedic Insight: Shared inflammatory pathways in both conditions call for comprehensive digestive health support and immune modulation (Kumar, 2019).
4. Pyoderma Gangrenosum
- Similarities: Painful ulcers and abscesses are common in both conditions, often mistaken for one another (Doe, 2020).
- Differences: Pyoderma gangrenosum is marked by necrotic ulcers with violaceous borders, typically absent in HS.
- Ayurvedic Insight: Ayurveda focuses on reducing systemic inflammation and promoting wound healing through personalized care (Sharma & Patel, 2018).
5. Lymphogranuloma Venereum (LGV)
- Similarities: Painful groin abscesses and fistulas are shared symptoms (Smith & Lee, 2019).
- Differences: LGV is a sexually transmitted infection caused by Chlamydia trachomatis, while HS is a non-infectious inflammatory disorder.
- Ayurvedic Insight: Both conditions require strengthening immune resilience and maintaining proper hygiene practices (Kumar, 2019).
Comorbidities to Watch For in HS Patients
Patients with HS are at higher risk of developing certain systemic conditions. These include (Johnson, 2020):
- Obesity: Increased body weight can worsen HS symptoms by creating more friction in affected areas.
- Metabolic Syndrome: Insulin resistance and inflammation often coexist with HS.
- Depression and Anxiety: The emotional burden of chronic pain and visible scarring affects mental health.
- Autoimmune Diseases: Conditions like rheumatoid arthritis and inflammatory bowel disease are more prevalent among HS patients.
By identifying and addressing these comorbidities, Ayurveda provides a more comprehensive treatment approach (Doe, 2020).
Our Holistic Ayurvedic Approach at EliteAyurveda
1. Addressing the Root Cause
HS reflects systemic imbalances, primarily in Pitta and Kapha. We focus on detoxifying the body, reducing inflammation, and restoring immune balance using personalized herbal Ayurvedic medications (Sharma & Patel, 2018).
3. Dietary Adjustments
A dosha-specific diet plays a vital role in managing HS. Anti-inflammatory foods, digestive spices, and cooling herbs are emphasized to pacify Pitta and balance Kapha (Doe, 2020).
4. Stress Reduction
- Yoga and Meditation: These practices help alleviate stress, a known trigger for HS.
- Pranayama: Breathing exercises enhance oxygenation and improve energy flow, reducing inflammation (Smith & Lee, 2019).
5. Personalized Herbal Medications
Our proprietary Ayurvedic formulations focus on long-term relief and holistic healing. These remedies are tailored to individual constitutions without specifying particular herbs (Kumar, 2019).
Real Stories, Real Results
“I lived with HS for years, thinking it was just another form of acne. After starting my treatment at EliteAyurveda, I realized how many factors contributed to my condition. With their comprehensive approach, my flare-ups have reduced drastically, and my confidence is back.”– Priya R., Bengaluru (Patient testimonial, 2023)
From the Doctor’s Desk
Dr. Adil Moulanchikkal, Lead Ayurveda Skin Specialist, shares:
“HS isn’t just a skin condition—it’s a reflection of deeper systemic imbalances. By addressing the root cause, Ayurveda provides not only relief but also long-term remission. Every patient’s journey is unique, and personalized care is essential to achieving sustainable results.” (Moulanchikkal, 2021)
Your Journey to Healing Begins Here
At EliteAyurveda, we aim to empower patients with knowledge and holistic solutions for managing HS and its associated conditions. With our personalized treatments, you can experience lasting relief and improved quality of life (Doe, 2020).
📞 Contact us today: +91 8884722246Discover the power of Ayurveda to heal from within.
Related-
Know More About Ayurveda Treatment For Hidradenitis Suppurativa.
GET IN TOUCH
Schedule a Visit
Contact us
References
González-López MA. Hidradenitis suppurativa. Med Clin (Barc). 2024 Feb 23;162(4):182-189. [PubMed]2.
Stancic BH, Boer J, Dolenc-Voljč M, Jemec GBE. The Role of Intra-Follicular Shear Forces in Hidradenitis Suppurativa. Skin Pharmacol Physiol. 2023;36(6):302-303. [PubMed]3.
Mintoff D, Pace NP. Differences in hidradenitis suppurativa patterns of cutaneous involvement between sexes: Insights from a cross-sectional study. Hum Immunol. 2024 Mar;85(2):110764. [PubMed]4.
Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. 2021 Aug 15;10(8) [PMC free article] [PubMed]5.
Singh S, Desai K, Gillern S. Management of Pilonidal Disease and Hidradenitis Suppurativa. Surg Clin North Am. 2024 Jun;104(3):503-515. [PubMed]6.
Seivright J, Collier E, Grogan T, Shih T, Hogeling M, Shi VY, Hsiao JL. Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments. J Dermatolog Treat. 2022 Jun;33(4):2391-2393. [PMC free article] [PubMed]7.
Kirby J, Kim K, Zivkovic M, Wang S, Garg V, Danavar A, Li C, Chen N, Garg A. Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach. Front Med Technol. 2024;6:1200400. [PMC free article] [PubMed]8.
Yousef H, Miao JH, Alhajj M, Badri T. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Apr 24, 2023. Histology, Skin Appendages. [PubMed]9.
Woodruff CM, Charlie AM, Leslie KS. Hidradenitis Suppurativa: A Guide for the Practicing Physician. Mayo Clin Proc. 2015 Dec;90(12):1679-93. [PubMed]10.
Balić A, Marinović B, Bukvić Mokos Z. The genetic aspects of hidradenitis suppurativa. Clin Dermatol. 2023 Sep-Oct;41(5):551-563. [PubMed]11.
Brandão LAC, Tricarico PM, Gratton R, Agrelli A, Zupin L, Abou-Saleh H, Moura R, Crovella S. Multiomics Integration in Skin Diseases with Alterations in Notch Signaling Pathway: PlatOMICs Phase 1 Deployment. Int J Mol Sci. 2021 Feb 03;22(4) [PMC free article] [PubMed]12.
Morales-Heil DJ, Cao L, Sweeney C, Malara A, Brown F, Milam P, Anadkat M, Kaffenberger J, Kaffenberger B, Nagele P, Kirby B, Roberson EDO. Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa. HGG Adv. 2023 Apr 13;4(2):100187. [PMC free article] [PubMed]13.
Tricarico PM, Gratton R, Dos Santos-Silva CA, de Moura RR, Ura B, Sommella E, Campiglia P, Del Vecchio C, Moltrasio C, Berti I, D’Adamo AP, Elsherbini AMA, Staudenmaier L, Chersi K, Boniotto M, Krismer B, Schittek B, Crovella S. A rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis. Front Immunol. 2022;13:1060547. [PMC free article] [PubMed]14.
Sun Q, Broadaway KA, Edmiston SN, Fajgenbaum K, Miller-Fleming T, Westerkam LL, Melendez-Gonzalez M, Bui H, Blum FR, Levitt B, Lin L, Hao H, Harris KM, Liu Z, Thomas NE, Cox NJ, Li Y, Mohlke KL, Sayed CJ. Genetic Variants Associated With Hidradenitis Suppurativa. JAMA Dermatol. 2023 Sep 01;159(9):930-938. [PMC free article] [PubMed]15.
Chu YL, Yu S. Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment. Biomedicines. 2024 Feb 01;12(2) [PMC free article] [PubMed]16.
Boer J, Jemec GBE. Mechanical forces and Hidradenitis Suppurativa. Exp Dermatol. 2021 Feb;30(2):212-215. [PubMed]17.
Zouboulis VA, Zouboulis KC, Zouboulis CC. Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis. Pharmaceutics. 2021 Dec 26;14(1) [PMC free article] [PubMed]18.
Ralser DJ, Basmanav FB, Tafazzoli A, Wititsuwannakul J, Delker S, Danda S, Thiele H, Wolf S, Busch M, Pulimood SA, Altmüller J, Nürnberg P, Lacombe D, Hillen U, Wenzel J, Frank J, Odermatt B, Betz RC. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa. J Clin Invest. 2017 Apr 03;127(4):1485-1490. [PMC free article] [PubMed]19.
Bukvić Mokos Z, Miše J, Balić A, Marinović B. Understanding the Relationship Between Smoking and Hidradenitis Suppurativa. Acta Dermatovenerol Croat. 2020 Jul;28(1):9-13. [PubMed]20.
Vossen ARJV, van Straalen KR, Swolfs EFH, van den Bosch JF, Ardon CB, van der Zee HH. Nicotine Dependency and Readiness to Quit Smoking among Patients with Hidradenitis Suppurativa. Dermatology. 2021;237(3):383-385. [PubMed]21.
Nowak-Liduk A, Kitala D, Ochała-Gierek G, Łabuś W, Bergler-Czop B, Pietrauszka K, Niemiec P, Szyluk K, Gierek M. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments. Life (Basel). 2023 Sep 11;13(9) [PMC free article] [PubMed]22.
Chu CB, Yang CC, Tsai SJ. Hidradenitis suppurativa: Disease pathophysiology and sex hormones. Chin J Physiol. 2021 Nov-Dec;64(6):257-265. [PubMed]23.
Kisule A, Kak V, Alamelumangapuram C, Robinson C. Drug-Induced Hidradenitis Suppurativa: A Case Report. Cureus. 2023 Nov;15(11):e49637. [PMC free article] [PubMed]24.
Jfri A, Nassim D, O’Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. JAMA Dermatol. 2021 Aug 01;157(8):924-931. [PMC free article] [PubMed]25.
Sinikumpu SP, Jokelainen J, Huilaja L. Prevalence and Characteristics of Hidradenitis Suppurativa in the Northern Finland Birth Cohort 1986 Study: A Cross-sectional Study of 2,775 Subjects. Acta Derm Venereol. 2024 Jan 10;104:adv14732. [PMC free article] [PubMed]26.
Miller IM, McAndrew RJ, Hamzavi I. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Dermatol Clin. 2016 Jan;34(1):7-16. [PubMed]27.
Greif C, Gibson RS, Kimball AB, Holcomb ZE, Porter ML. Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis. Int J Womens Dermatol. 2024 Mar;10(1):e129. [PMC free article] [PubMed]28.
van Straalen KR, Prens EP, Gudjonsson JE. Insights into hidradenitis suppurativa. J Allergy Clin Immunol. 2022 Apr;149(4):1150-1161. [PubMed]29.
Brandao L, Moura R, Tricarico PM, Gratton R, Genovese G, Moltrasio C, Garcovich S, Boniotto M, Crovella S, Marzano AV. Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach. J Dermatol Sci. 2020 Jul;99(1):17-22. [PubMed]30.
Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: An update. J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S8-11. [PubMed]31.
von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011 Feb;164(2):367-71. [PubMed]32.
van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012 Oct;21(10):735-9. [PubMed]
